Neil Solomons

Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus

Acute kidney injury

Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

Systemic lupus erythematosus

Update on Lupus Nephritis

Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches

Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?

The JAK/STAT signaling pathway: from bench to clinic

Systemic Lupus Erythematosus

Current therapy of the pemphigus group

Systemic lupus erythematosus

Lupus nephritis: where are we now?

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation

2015 ESC Guidelines for the management of infective endocarditis

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis

Treating Pemphigus Vulgaris with Prednisone and Mycophenolate Mofetil: A Multicenter, Randomized, Placebo-Controlled Trial

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study

Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis